Predicting response to bevacizumab in metastatic breast cancer by DNA methylation

Walter Pulverer; Simon Gampenrieder; G Rinnerthaler; Andreas Weinhäusel; C. Hufnagel; H Hackl; Cornelia Hauser-Kronberger; Brigitte Mlineritsch; R. Greil

Predicting response to bevacizumab in metastatic breast cancer by DNA methylation

Walter Pulverer (Speaker), Simon Gampenrieder, G Rinnerthaler, Andreas Weinhäusel, C. Hufnagel, H Hackl, Cornelia Hauser-Kronberger, Brigitte Mlineritsch, R. Greil

Molecular Diagnostics

Research output: Poster presentation without proceedings

Original language	English
Publication status	Published - 2018
Event	CCC Trio Meeting - Duration: 6 Apr 2018 → 7 Apr 2018

Conference

Conference	CCC Trio Meeting
Period	6/04/18 → 7/04/18

Research Field

Molecular Diagnostics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{e6315e2032f34f23ab039ef62b42ebba,

title = "Predicting response to bevacizumab in metastatic breast cancer by DNA methylation",

author = "Walter Pulverer and Simon Gampenrieder and G Rinnerthaler and Andreas Weinh{\"a}usel and C. Hufnagel and H Hackl and Cornelia Hauser-Kronberger and Brigitte Mlineritsch and R. Greil",

year = "2018",

language = "English",

note = "CCC Trio Meeting ; Conference date: 06-04-2018 Through 07-04-2018",

}

TY - CONF

T1 - Predicting response to bevacizumab in metastatic breast cancer by DNA methylation

AU - Gampenrieder, Simon

AU - Rinnerthaler, G

AU - Weinhäusel, Andreas

AU - Hufnagel, C.

AU - Hackl, H

AU - Hauser-Kronberger, Cornelia

AU - Mlineritsch, Brigitte

AU - Greil, R.

A2 - Pulverer, Walter

PY - 2018

Y1 - 2018

M3 - Poster presentation without proceedings

T2 - CCC Trio Meeting

Y2 - 6 April 2018 through 7 April 2018

ER -